Harvard Bioscience (HBIO) Interest Expenses (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Interest Expenses of $1.4 million for Q1 2026, up 52.29% year-over-year from $939000.0 in Q1 2025, and up 214.49% quarter-over-quarter from -$1.2 million in Q4 2025.
Harvard Bioscience (HBIO) Interest Expenses (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Interest Expenses for 17 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 52.29% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 52.29% YoY), while the FY2025 annual figure was $19.9 million, up 11.84% from the prior year.
- Interest Expenses improved to $1.4 million in Q1 2026 per HBIO's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $10.4 million in Q3 2022 and bottomed at -$1.4 million in Q4 2022.
- Historically, Interest Expenses has averaged $1.7 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 158.4% — and 2025, when it plunged 353.35%.
- Harvard Bioscience's Interest Expenses stood at -$1.4 million in 2022, then jumped by 158.4% to $789000.0 in 2023, then sank by 37.52% to $493000.0 in 2024, then slumped by 353.35% to -$1.2 million in 2025, then surged by 214.49% to $1.4 million in 2026.
- Business Quant data shows HBIO's Interest Expenses at $1.4 million in Q1 2026, -$1.2 million in Q4 2025, and $949000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.80 Mn |
| Jun 30, 2026 | 8.80 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Dec 31, 2025 | -1.25 Mn |
| Sep 30, 2025 | 949,000.00 |
| Sep 30, 2025 | 949,000.00 |
| Jun 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 939,000.00 |
| Mar 31, 2025 | 939,000.00 |
| Dec 31, 2024 | 493,000.00 |
| Dec 31, 2024 | 493,000.00 |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |